Positron (POSC) Stock Price

Positron Price

OTC·CLOSED
1.74
​
Market closed

Revenue at Positron has contracted by 10.3% per year over the past 22 years to 461,452.00 USD. For Positron, the net margin of -2,297.8% is down versus -67.5% a few years ago.

Positron stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Positron business model & stock analysis

Positron Corp is a company in the medical technology industry specializing in the development of PET (positron emission tomography) systems and solutions. The company was founded in 1983 as Positron Corporation with headquarters in Houston, Texas, USA. Initially focused on research and development of technologies for radiation therapy, the company shifted its focus to PET imaging and became a pioneer in the field. Positron Corp's business model is based on selling PET systems and related solutions and services to medical facilities and organizations. The company offers both stationary and mobile systems for various applications such as cancer diagnostics. Positron Corp is divided into different divisions specializing in different areas of PET technology, including the development, production, and distribution of PET modules, systems, and software solutions. The flagship product of Positron Corp is the Total-body PET module, which enables complete imaging of the human body and is unique in the medical field. The module was designed to meet the need for whole-body imaging in cancer diagnostics and offers patients a non-invasive way to monitor cancer cells and metastases. In addition to the Total-body PET module, the company also offers specialized solutions for various areas of PET imaging, including a portable PET scanner suitable for use in emergency rooms or intensive care units. Another area of Positron Corp is the development and production of radiation therapy products. The company has developed a range of radiopharmaceuticals that can be used in cancer treatment, including radioisotopes such as fluorine-18, used for labeling molecules in cancer diagnostics, and yttrium-90, used in radiation therapy for the treatment of liver tumors. To ensure that its products remain at the forefront of technology, Positron Corp is heavily involved in research and development. The company collaborates closely with leading research and development companies to develop innovative solutions and technologies that meet the demands of the medical technology industry. Overall, Positron Corp has established itself as a key player in the medical technology industry, developing innovative solutions and technologies for PET imaging and radiation therapy. The company is committed to improving the standard of medical diagnostics and treatment, contributing to the improvement of healthcare.

Frequently asked questions about Positron

Positron Corp's business model focuses on the development and commercialization of advanced cardiac imaging technologies. As a leading healthcare company, Positron Corp specializes in positron emission tomography (PET) systems, which provide high-resolution imaging for early detection and diagnosis of cardiovascular disease. With a strong emphasis on innovation, the company strives to enhance patient care by offering cutting-edge imaging solutions. Positron Corp's business model centers around delivering state-of-the-art cardiac imaging technology, contributing to improved patient outcomes and revolutionizing the field of cardiovascular medicine.

Positron Corp primarily operates in the medical technology industry.

The main competitors of Positron Corp in the market include companies like General Electric (GE), Siemens Healthineers, and Philips Healthcare.

Positron Corp is a renowned company specializing in the development and manufacturing of cardiac imaging systems and solutions. Established in [year], Positron Corp has made significant contributions to the field of nuclear cardiology. With a strong focus on research and innovation, the company has continuously progressed and introduced advanced technologies to improve medical imaging and diagnosis. Positron Corp's dedication to promoting early detection of cardiovascular diseases and enhancing patient care has earned them a reputable position in the healthcare industry. With their expertise and commitment, Positron Corp remains at the forefront of nuclear cardiology advancements, driving positive change and improving lives worldwide.

Positron Corp has achieved several significant milestones. The company successfully developed and commercialized innovative medical imaging devices, specifically focused on positron emission tomography (PET) scanners. These advanced scanners revolutionized the medical industry by providing high-resolution and accurate imaging for the diagnosis and treatment of various diseases, including cancer. Positron Corp also collaborated with leading healthcare institutions and research centers worldwide to enhance their technology and expand its applications. Additionally, the company demonstrated consistent growth and profitability over the years, earning recognition for its dedication to advancing medical imaging technology. Positron Corp's milestones reflect its commitment to improving healthcare outcomes and solidify its position as a leader in the PET imaging market.

Positron Corp is primarily present in the United States.

The values and corporate philosophy that Positron Corp represents revolve around innovation, excellence, and customer satisfaction. As a leading company in its field, Positron Corp prides itself on creating cutting-edge solutions that meet the evolving needs of its clients. With a commitment to quality and technological advancements, the company strives to deliver outstanding products and services that exceed expectations. Positron Corp also emphasizes teamwork, integrity, and a strong work ethic, fostering a collaborative and inclusive environment for its employees. Through its dedication to these core values, Positron Corp continues to drive growth and provide value to its stakeholders.

Converted at the current exchange rate, the Positron share trades at 1.55 EUR (1.74 USD).

Positron Corp is a leading company in the development and manufacture of solutions for medical imaging and radiation therapy. Their business model consists of three different divisions: medical technology, radiopharmaceuticals, and service.

The revenue cannot currently be calculated for Positron.

The profit cannot currently be calculated for Positron.

The P/E ratio cannot be calculated for Positron at the moment.

The P/S cannot be calculated for Positron currently.

The Eulerpool Quality Score for Positron is 1/10.

The ISIN of Positron is US7373976049. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Positron is A14RHT. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Positron is POSC. The ticker symbol is used to trade Positron shares on the stock exchange.

Fair ValueTerminal
1.53 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
20,975.09 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website positron.com
Currency
USD
Initial public offering
Feb 10, 1994
ISIN
US7373976049
Cusip
737397604
Sedol
BVGH8B8
Market capitalization
16.11 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
11.16
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-312.68 %
Last updated Oct 21, 2026, 6:03 PM

Positron Ticker

OTC · POSC

Positron FIGI

POSC:US · BBG000BHHCV0POSC:PQ · BBG000BHHJQ1POSC:UV · BBG000BHHKW1

All fundamentals and in-depth analysis of Positron

Our stock analysis for Positron stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Positron. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.